Genomic medicine startup Lucence announced that the development of the SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) kit, a sample collection medical device to facilitate more accessible testing of viral infections such as COVID-19.
WHY IT MATTERS
Currently, definitive diagnosis of RNA viral infections such as COVID-19 requires patients with respiratory infections...
